Author:
Bowyer Annette Elizabeth,Kitchen Steve,Ezban Mirella
Reference14 articles.
1. A factor VIIIa-mimetic bispecific antibody, Mim8, ameliorates bleeding upon severe vascular challenge in hemophilia A mice;Østergaard;Blood,2021
2. Effects of emicizumab on APTT, one-stage and chromogenic assays of factor VIII in artificially spiked plasma and in samples from haemophilia A patients with inhibitors;Bowyer;Haemophilia,2020
3. Laboratory coagulation tests and emicizumab treatment A United Kingdom Haemophilia Centre Doctors' Organisation guideline;Jenkins;Haemophilia,2020
4. WFH Guidelines for the Management of Hemophilia panelists and co-authors. WFH Guidelines for the Management of Hemophilia, 3rd edition;Srivastava;Haemophilia,2020
5. Bowyer AE, Kitchen S, Ezban M. Assessment of a new chromogenic FVIII assay in severe haemophilia A plasma containing emicizumab (abstract), in THSNA. 2020: virtual.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献